Mollica, Michelle A.
Zaleta, Alexandra K.
Gallicchio, Lisa
Brick, Rachelle
Jacobsen, Paul B.
Tonorezos, Emily
Castro, Kathleen M.
Miller, Melissa F.
Funding for this research was provided by:
AbbVie
Amgen
AstraZeneca United States
Bristol-Myers Squibb
Celgene
Eli Lilly and Company
EMD Serono
Genentech
North Carolina GlaxoSmithKline Foundation
Janssen Pharmaceuticals
Jazz Pharmaceuticals Canada
Novartis Pharmaceuticals Corporation
Pfizer
Pharmacyclics
Seagen
Takeda Pharmaceuticals U.S.A.
Article History
Received: 22 September 2023
Accepted: 16 January 2024
First Online: 30 January 2024
Declarations
:
: Ethical and Independent Review Services (E&I, Independence, MO) served as the IRB of record (Study #16036). All procedures were in accordance with the ethical standards of the institutional research committee for studies involving human participants and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all participants.
: The authors affirm that human research participants provided informed consent for publication of the data in all tables.
: The article was prepared as part of some of the authors’ (MAM, LG, PJ, ET, KC) official duties as employees of the US Federal Government. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the National Cancer Institute.This study has not been previously presented.
: The authors report the following conflicts of interest. Institutional research support was granted to the Cancer Support Community and not individual study authors:Dr. Zaleta: Institutional research funding from: Astellas Pharma, Boston Scientific Foundation, Gilead Sciences, Novartis, Pfizer, Seagen.Dr. Miller: Institutional research funding from: Astellas Pharma, BeiGene, Bristol-Myers Squibb, Genentech (a member of the Roche Group), Geron, Gilead Sciences, GlaxoSmithKline, Janssen Pharmaceuticals, Merck, Novartis, Pfizer, Taiho Oncology, and Takeda Pharmaceutical Company.Drs. Mollica, Gallicchio, Brick, Jacobsen, Tonorezos, and Ms. Castro do not report any conflicts of interest.